Eli Lilly's Kisunla was approved in the U.S. for Alzheimer's last year, but now advisers to the European Medicines Agency say ...
A European health committee has rejected Eli Lilly’s Alzheimer’s drug, Kisunla, because of safety concerns about possible ...
The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...
The European Commission (EC) and the Medicines and Healthcare products Regulatory Agency (MHRA ... and may change due to future developments. Disclaimer: only for communication and scientific ...
For the first time, the European Medicines Agency has recognized AI software for the diagnosis of fatty liver hepatitis as scientifically valid. The Committee for Medicinal Products for Human Use ...
CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission of a�Type II variation application�to the ...